I think you will see the share price recover as the market digests that there was nothing sinister (e.g. an earnings downgrade) about the CEO leaving and the stock was oversold.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025